Pharmaceutical - Sanofi

Filter

Current filters:

Sanofi

Popular Filters

1 to 25 of 268 results

Drugmakers “outraged” at England's Cancer Drugs Fund decision to remove drugs from coverage

Drugmakers “outraged” at England's Cancer Drugs Fund decision to remove drugs from coverage

08-01-2015

England’s Cancer Drugs Fund is overspent and 42 drugs are being reassessed as price caps are brought…

AvastinEisaiHalavenHealthcareJevtanaKadcylaOncologyPharmaceuticalPricingRocheSanofiUKZaltrap

Sanofi Pasteur gains FDA approval of Fluzone Intradermal Quadrivalent for adults

Sanofi Pasteur gains FDA approval of Fluzone Intradermal Quadrivalent for adults

13-12-2014

French pharma major Sanofi’s vaccines division, Sanofi Pasteur, has received approval from the US Food…

Anti-viralsFluzonePharmaceuticalRegulationSanofiSanofi PasteurUSAVaccines

Sanofi accused of $34 million kickbacks by former paralegal employee

Sanofi accused of $34 million kickbacks by former paralegal employee

05-12-2014

Allegations have been made that French drug major Sanofi and members of its executive took part in a…

FranceLantusLegalNephrology and HepatologyPharmaceuticalSanofi

Evotec and Sanofi negotiate 250 million euro strategic collaboration

Evotec and Sanofi negotiate 250 million euro strategic collaboration

03-12-2014

German biotech company Evotec has entered into exclusive negotiations with French drug major Sanofi on…

EvotecFranceGermanyPharmaceuticalResearchSanofi

FDA approves Sanofi’s Priftin for latent TB

FDA approves Sanofi’s Priftin for latent TB

03-12-2014

French pharma major Sanofi says that the US Food and Drug Administration has approved Priftin (rifapentine),…

Antibiotics and Infectious diseasesPharmaceuticalPriftinRegulationSanofiUSA

Pozen shares slide as gastric ulcer collaboration with Sanofi ends

Pozen shares slide as gastric ulcer collaboration with Sanofi ends

02-12-2014

French drug major Sanofi and North Carolina-based pharma company Pozen have agreed to end their collaboration…

FranceGastro-intestinalsLicensingPA8140/PA32540PharmaceuticalPozenSanofiUSA

CHMP grants positive opinion to Sanofi/Genzyme's Cerdelga in Gaucher disease

CHMP grants positive opinion to Sanofi/Genzyme's Cerdelga in Gaucher disease

21-11-2014

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued…

CerdelgaEuropeGenzymePharmaceuticalRegulationSanofi

Pharma companies can still improve access to medicines, report shows

Pharma companies can still improve access to medicines, report shows

17-11-2014

Top pharma companies are doing more to improve access to medicine in developing countries over the last…

GlaxoSmithKlineGlobalMarkets & MarketingNovo NordiskPharmaceuticalSanofi

Biologics will complement statins in cholesterol treatment space, says GlobalData

Biologics will complement statins in cholesterol treatment space, says GlobalData

11-11-2014

Biologics will play an influential role in shaping the future of cardiovascular drug treatment, in particular…

alirocumabAmgenCardio-vascularevolocumabMarkets & MarketingPharmaceuticalRegeneronSanofiUSA

Positive results for Sanofi/Regeneron’s dupilumab in asthma

Positive results for Sanofi/Regeneron’s dupilumab in asthma

11-11-2014

French pharma major Sanofi and US partner Regeneron Pharmaceuticals have released positive results from…

dupilumabFrancePharmaceuticalRegeneron PharmaceuticalsResearchRespiratory and PulmonarySanofi

Diabetes drugs could potentially reverse Alzheimer's damage, say UK researchers

Diabetes drugs could potentially reverse Alzheimer's damage, say UK researchers

04-11-2014

A new study has suggested that drugs currently being used to treat diabetes also have the potential to…

liraglutidelixisenatideNeurologicalNovo NordiskPharmaceuticalResearchSanofiUK

Sanofi ousts CEO Viehbacher, despite recent denials

Sanofi ousts CEO Viehbacher, despite recent denials

29-10-2014

Just a day after French pharma major Sanofi denied that the future of its chief executive was under discussion,…

BoardroomFranceManagementPharmaceuticalSanofi

Sanofi's third quarter figures are on track but shares fall on diabetes price competition warning

Sanofi's third quarter figures are on track but shares fall on diabetes price competition warning

28-10-2014

French drug major Sanofi’s third-quarter earnings are in focus, but the company’s shares have plummeted…

FinancialFranceGenzymePharmaceuticalSanofi

UPDATED: Sanofi chief executive Viehbacher allegedly issues letter to company board defending his position

UPDATED: Sanofi chief executive Viehbacher allegedly issues letter to company board defending his position

28-10-2014

Chris Viehbacher, chief executive of French drug major Sanofi, has urged the company’s board to clarify…

BoardroomFranceLantusPharmaceuticalSanofi

Ferring Pharma regains rights to DDAVP portfolio

Ferring Pharma regains rights to DDAVP portfolio

22-10-2014

Privately-held Switzerland-headquartered Ferring Pharmaceuticals says it has acquired DDAVP (desmopressin…

DDAVPDiabetesFerring PharmaceuticalsGenito-urinaryLicensingPharmaceuticalSanofiSwitzerland

Age is a factor when looking at diabetes management, Sanofi survey finds

Age is a factor when looking at diabetes management, Sanofi survey finds

15-10-2014

The US subsidiary of French pharma major Sanofi has announced the findings of a new survey that reveals…

DiabetesPharmaceuticalResearchSanofiUSA

Sanofi receives allegations of improper payments dating back seven years

Sanofi receives allegations of improper payments dating back seven years

07-10-2014

French pharma major Sanofi has notified the US Department of Justice and the US Securities and Exchange…

East AfricaFranceLegalMiddle EastPharmaceuticalSanofiUS Department of JusticeUS Securities and Exchange Commission

Brilinta preferred over clopidogrel in latest AHA/ACC guideline

Brilinta preferred over clopidogrel in latest AHA/ACC guideline

06-10-2014

Anglo-Swedish pharma major AstraZeneca today confirmed that the American Heart Association (AHA) and…

AstraZenecaBrilintaCardio-vascularClopidogrelDaiichi SankyoEli LillyPharmaceuticalprasugrelRegulationSanofiticagrelorUSA

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

01-10-2014

French drug major Sanofi and US biotech company Regeneron's dupilumab has met all primary and secondary…

dupilumabFrancePharmaceuticalRegeneronResearchRespiratory and PulmonarySanofiUSA

Sanofi may build new plant in Russia

Sanofi may build new plant in Russia

30-09-2014

French pharma major Sanof plans to build a new plant in Russia, which is expected to be located in the…

AsiaPharmaceuticalProductionRussiaSanofi

1 to 25 of 268 results

Back to top